Ziprasidone-associated mania in a case of obssessive-compulsive disorder

CNS Spectrums

Volumn 12, Issue 8, 2007, Pages 578-579

  Wickham, Randall ^a   Varma, Anjali ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; CLONAZEPAM; FEXOFENADINE; FLUVOXAMINE; HYDROXYZINE; NITROPRUSSIDE SODIUM; VENLAFAXINE; ZIPRASIDONE;

ADULT; ANAMNESIS; CASE REPORT; CLINICAL FEATURE; COGNITIVE THERAPY; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; HUMAN; LABORATORY TEST; LETTER; LOW DRUG DOSE; MALE; MANIA; NEUROLOGIC EXAMINATION; OBSESSIVE COMPULSIVE DISORDER; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

EID: 34548265763     PISSN: 10928529     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1092852900021350     Document Type: Letter

References (5)

1. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: America Psychiatric Association; 1994.
2. Privitera MR, Maharaj K. Mania from dose related ziprasidone augmentation of an SSRI. J Clin Psychiatry. 2003;64:1393-1394.
3. Patel NC, Keck PE Jr. Ziprasidone: efficacy and safety in patients with bipolar disorder. Expert Rev Neurother. 2006;6:1129-1138.
4. Crane DL. Ziprasidone as an augmenting agent in treatment of anxiety-spectrum disorders. CNS Spectr. 2005;10:176-179.
5. Duggal H, Sigh I. Ziprasidone and hypomania. CNS Spectr. 2005;10:606.